VSEE HEALTH, INC. — Form 8-K
Filed July 31, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
VSee Health issued a $336,000 convertible promissory note (with $300,000 purchase price + $36,000 OID) to Labrys Fund II, L.P. on June 30, 2026. The note bears 12% annual interest, matures in 12 months, and converts to common stock at 75% of the 10-day trailing bid price. Conversion requires shareholder approval for issuances above 6M shares (Exchange Cap). Amortization payments begin December 2026. The Buyer withheld $9,000 ($5,000 legal fees + $4,000 due diligence costs) from the $300,000 purchase price.
Why this rating
$300K funding is ~1.6% of $18.2M market cap—material but routine for microcap. Dilutive terms but standard for distressed financing. No operational impact yet.
See more from July 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.